ELDERPHARM

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 09, 2012 have recommend for consideration of Shareholders declaration of dividend @ 30% i.e. Rs.3/- per share of Rs.10/- each.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 12, 2011 have recommended dividend @ 30% i.e. Rs. 3/- per share of Rs. 10/- each.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 18, 2010 have recommended for consideration of Shareholders declaration of dividend @ 30% i.e. Rs. 3/- per share.

Elder Pharmaceuticals Limited has informed the Exchange that the following decisions were taken at the Board Meeting held on the August 25, 2009 : 1) To recommend for consideration of Shareholders declaration of dividend @25% i.e. Rs. 2.50 per share. 2) To hold the Annual General Meeting of the Company on the September 29, 2009. 3) To keep transfer books closed from September 22, 2009 to September 29, 2009 (both days inclusive) for the purpose of determining the eligible shareholders for dividend payment.

Elder Pharmaceuticals Limited has informed the Exchange that the Board Meeting was held on August 26, 2008 and the following decisions were taken at the said Board meeting: (1) To hold the Annual General Meeting of the Company on September 30, 2008. (2) To recommend for consideration of shareholders' declaration of dividend @ 25%. (3) To keep transfer books closed from September 22, 2008 to September 30, 2008 ( both days inclusive).

Elder Pharmaceuticals Limited has informed the Exchange that the following decisions were taken at the Board Meeting held on August 28, 2007: 1) To hold the Annual General Meeting of the Company on September 27, 2007. 2) To recommend for consideration of shareholders' declaration of dividend @25%. 3) To keep transfer books closed from September 20, 2007 to September 27, 2007 (Both days inclusive). 4) To make 51% acquisition in Biomeda Group of Bulgaria. 5) To appoint subject to the approval of Shareholders, Mr. Yusuf Karim Khan as an Additional Director and Executive Director for a period of f

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors in its meeting held on August 25, 2006 has recommended dividend @25%.

Elder Pharmaceuticals Limited has informed the Exchange that the BODs of the Company in its meeting held on August 17, 2005, have taken the following decisions: 1) To hold the AGM of the Company on September 27, 2005. 2) To recommend for consideration of shareholders' declaration of dividend @ 25%. The Company has further informed that the Board has also approved the long term contract for manufacture and supply of dietary fibre supplement in collaboration with Ceejay Healthcare.